CACNA1C-Related Brugada Syndrome

CACNA1C-related Brugada syndrome is a heart rhythm problem. It makes the lower chambers of the heart (the ventricles) beat in a dangerous way. It can cause fainting or even sudden death in people with a heart that looks normal on scans. Doctors see a special pattern on an ECG (a heart tracing) in the chest leads near the right side of the chest (V1–V3). This pattern is called a type-1 Brugada pattern. It shows a “coved” ST elevation followed by an inverted T wave. The risk comes from ventricular fibrillation, which is a very fast and chaotic rhythm. PMC+1

CACNA1C-related Brugada syndrome is a genetic form caused by changes (variants) in the CACNA1C gene. This gene builds the main pore-forming part (α1C subunit) of the heart’s L-type calcium channel (CaV1.2). That channel lets calcium flow into heart cells during each beat. When a disease-causing variant lowers this calcium current (loss-of-function), the electrical balance during the early part of each heartbeat shifts. This can create the Brugada ECG pattern and the risk of dangerous rhythms. In many patients with CACNA1C variants, the QT interval can also be shorter than normal. Overall, CACNA1C variants are an uncommon cause of Brugada syndrome but are well-documented in the medical literature. PMC+1

CACNA1C Brugada syndrome is a genetic heart-rhythm condition where changes (loss-of-function variants) in the CACNA1C gene reduce a key calcium current (L-type Ca²⁺, CaV1.2) in heart cells. This reduction alters the heart’s electrical signal—especially in the right ventricular outflow tract—so the ECG can show a “coved” ST elevation in V1–V3 (a Brugada type 1 pattern). People can be completely well, or they can develop fainting or dangerous ventricular arrhythmias (like ventricular fibrillation), particularly during fever, certain medicines, or electrolyte problems. Unlike Timothy syndrome (which involves CACNA1C gain-of-function and long-QT), the Brugada form is a loss-of-function phenotype more akin to other Brugada genotypes. The mainstays of care are trigger avoidance, aggressive fever control, careful drug selection, rapid treatment of electrical storms with isoproterenol infusion, consideration of quinidine for arrhythmia suppression, catheter ablation for recurrent arrhythmias from identifiable substrate, and ICD in selected high-risk patients. Family screening and genetic counseling are important. NCBI+3NCBI+3NCBI+3

Experts continue to refine how strong the evidence is for each “Brugada gene.” Early lists included many genes. Later, expert groups showed that some have strong proof and some have limited or disputed proof. For CACNA1C, several lines of clinical and laboratory evidence support a role in a small subset of patients (often with short QT), though classification differs between curation groups and has changed over time as new data appear. The bottom line: CACNA1C is not a common cause, but when a clearly damaging CACNA1C variant is present with the right ECG and clinical picture, it can explain the disease. panelapp.genomicsengland.co.uk+3PMC+3sads.org+3

---

Other names

• Brugada syndrome due to CACNA1C

• CaV1.2-related Brugada syndrome

• Calcium channel–related Brugada syndrome (BrS3 locus)

• Brugada syndrome with short QT due to CACNA1C (common association) sads.org

---

Types

1. Spontaneous type-1 Brugada pattern
   The diagnostic ECG pattern appears at rest without any drug challenge. This carries higher risk than drug-induced only. The same applies in CACNA1C-related cases. PMC

2. Drug-induced type-1 pattern
   The pattern appears only after a “provocation test” with a sodium-channel–blocking medicine (such as ajmaline or flecainide) done under monitoring. In CACNA1C disease, the trigger can still unmask the pattern. PMC

3. Fever-induced Brugada pattern
   High body temperature can bring out the ECG pattern and arrhythmias. This is true in many genetic backgrounds, including calcium-channel loss-of-function. PMC

4. Brugada with short QT phenotype
   In CACNA1C, the QT interval may be short because the L-type calcium current is reduced. This subtype is repeatedly reported. PubMed

5. Overlap phenotypes
   Rare families show both Brugada features and other channelopathy traits (e.g., early repolarization, short QT). CACNA1C can sit in this overlap space. PMC

---

Causes

Here “causes” means what can cause or unmask/worsen the Brugada pattern and arrhythmia risk in someone with a CACNA1C variant.

1. Pathogenic CACNA1C variant (loss-of-function)
   The core cause. It lowers L-type calcium current, making the right-ventricular epicardium more likely to repolarize early, creating the Brugada pattern and vulnerability to ventricular fibrillation. PMC

2. Additional genetic modifiers
   Other variants (for example in SCN5A, CACNB2, or KCND3) can add up and increase risk or expressivity in families. OUP Academic

3. Fever
   High temperature changes ion channel behavior and often exposes the ECG pattern or triggers arrhythmia. Treat fever aggressively. PMC

4. Sodium-channel–blocking medications (e.g., flecainide, procainamide, ajmaline)
   These drugs can reveal the Brugada ECG and provoke arrhythmias. They are used for diagnosis under monitoring but can be dangerous casually. PMC

5. Some antidepressants and antipsychotics (certain tricyclics, etc.)
   They can have sodium-channel effects and unmask Brugada patterns in susceptible people. PMC

6. Cocaine and other illicit stimulants
   Can block sodium channels and provoke malignant rhythms. PMC

7. Excess alcohol intake
   Alcohol can alter autonomic tone and channel function, increasing arrhythmia risk. PMC

8. Large heavy meals at night
   Vagal surges during sleep and after heavy meals may trigger events in Brugada syndrome. PMC

9. Electrolyte imbalance: low potassium
   Hypokalemia can worsen repolarization abnormalities and trigger arrhythmias. PMC

10. Electrolyte imbalance: low calcium or magnesium
    These ions affect repolarization. Low levels raise risk in channelopathies. PMC

11. Dehydration
    Can concentrate electrolytes and increase sympathetic/vagal swings, destabilizing the substrate. PMC

12. Severe emotional stress
    Sudden adrenergic surges can trigger ventricular fibrillation in susceptible hearts. PMC

13. Strenuous unaccustomed exercise
    Rapid shifts in autonomic tone and temperature can unmask arrhythmias. PMC

14. Sleep (vagal predominance)
    Many events happen at night during high vagal tone, which promotes the Brugada substrate. PMC

15. High right-sided chest lead placement errors
    Misplacement can hide or reveal patterns; using higher intercostal spaces can reveal true disease. PMC

16. Brugada-pattern drugs outside the hospital
    Some antiarrhythmics, anesthetics, or antihistamines with sodium-channel effects can be risky. PMC

17. Viral illnesses with fever/inflammation
    Not just temperature—the inflammatory state may affect ion channels and autonomics. PMC

18. Hypoxia (low oxygen)
    Worsens electrical instability in already thin-margin action potentials. PMC

19. Hyperkalemia (high potassium) extremes
    Marked changes in potassium alter conduction and repolarization. PMC

20. Concomitant short-QT–causing variants
    When present with CACNA1C loss-of-function, the QT becomes short and the repolarization window narrows further, raising risk. PubMed

---

Symptoms and signs

1. Fainting (syncope)
   Brief loss of consciousness due to a short, self-ending ventricular arrhythmia. Often without warning. PMC

2. Nocturnal agonal breathing
   Gasping during sleep can reflect a dangerous rhythm at night. Family members may witness this. PMC

3. Palpitations
   Feeling of fast or irregular heartbeats. Can precede fainting. PMC

4. Seizure-like episodes
   Brief shaking can follow a faint from arrhythmia and be mistaken for epilepsy. ahajournals.org

5. Sudden cardiac arrest
   Collapse requiring CPR or a defibrillator shock. May be the first presentation. PMC

6. Dizziness or near-fainting
   Light-headed spells, especially at rest or at night. PMC

7. Chest discomfort
   Usually not due to blocked arteries; rather, pounding or tightness with arrhythmia. PMC

8. Symptoms during fever
   Fainting or palpitations that only appear when temperature is high. PMC

9. Family history of sudden death
   Especially in young adults, often during sleep. This is a crucial clue. PMC

10. Unexplained nighttime awakenings
    Waking with pounding heart or gasping. PMC

11. Post-exercise weakness or wooziness
    Due to autonomic swings that trigger arrhythmia in susceptible people. PMC

12. Episodes after alcohol
    Palpitations or syncope following heavy drinking. PMC

13. Symptoms with certain medicines
    New palpitations or fainting soon after starting a drug known to affect cardiac sodium channels. PMC

14. No symptoms (incidental ECG)
    Many people are asymptomatic; the pattern may be found on routine ECG. PMC

15. Short QT on ECG in some cases
    Especially with CACNA1C variants, the QT interval may be short. This is not a feeling, but a common finding linked to symptoms. PubMed

---

Diagnostic tests

A) Physical examination (bedside checks)

1. Vital signs (heart rate, blood pressure, temperature)
   Temperature is critical because fever can unmask the pattern or trigger arrhythmias. HR and BP are usually normal between episodes. PMC

2. Focused cardiovascular exam
   Most people have a normal-sounding heart with no murmurs, which helps differentiate from structural disease. PMC

3. Neurologic status after fainting
   A quick check helps distinguish fainting from primary seizures—important because arrhythmic syncope can look like a seizure. ahajournals.org

4. Family history mapping at the bedside
   A clinician documents sudden deaths, unexplained drownings, or nighttime deaths in relatives—strong clues to a heritable arrhythmia. PMC

5. Medication and substance review
   Identifies drugs that can unmask the Brugada pattern. Patients are counseled to avoid them. PMC

B) “Manual or bedside provocative maneuvers / simple tests

6. High right-precordial lead placement ECG (2nd–3rd intercostal space)
   This is a hands-on adjustment by the clinician. Moving V1–V2 higher can reveal the diagnostic pattern when standard placement is non-diagnostic. PMC

7. Fever challenge (controlled observation during fever)
   Not a drug test, but careful ECG monitoring during naturally occurring fever can show the pattern; treating the fever promptly is key. PMC

8. Orthostatic / standing ECG comparison
   Autonomic shifts with standing may modestly affect the pattern and symptoms; used adjunctively with other testing. PMC

9. Exercise test (treadmill) for differential diagnosis
   While Brugada events are typically at rest/night, exercise testing can help rule in/out other causes of syncope and observe ECG behavior. PMC

10. Tilt-table testing (when syncope is unclear)
    Helps separate reflex syncope from arrhythmic syncope; Brugada patients can also have reflex syncope, so clarifying the mechanism matters. PMC

C) Laboratory and pathological tests

11. Serum electrolytes (K⁺, Mg²⁺, Ca²⁺)
    Correcting low potassium, magnesium, or calcium decreases triggers for arrhythmias. PMC

12. Fever and infection labs (CBC, CRP)
    Identify infections driving fever, which must be treated rapidly in Brugada syndrome. PMC

13. Cardiac injury markers (troponin) when needed
    Used to rule out a heart attack if chest pain accompanies symptoms; Brugada syndrome usually shows normal troponin. PMC

14. Toxicology screen (when drug exposure is possible)
    Detects sodium-channel–active substances (e.g., cocaine, tricyclics) that can provoke the ECG pattern. PMC

15. Genetic testing (targeted or panel) including CACNA1C
    Looks for pathogenic variants in CACNA1C and other vetted Brugada genes. Interpretation requires expertise because gene validity varies by source and updates over time. Pathogenic CACNA1C variants are rare but recognized, often with short QT. PubMed+2PMC+2

D) Electrodiagnostic tests

16. 12-lead ECG (baseline)
    Main test. Doctors look for a type-1 Brugada pattern (coved ST elevation in V1–V2/V3). Pattern can be intermittent. PMC

17. 12-lead ECG with high right-precordial leads
    Repeating the ECG with V1–V2 in higher interspaces increases sensitivity to detect the pattern. PMC

18. Drug provocation test (ajmaline/flecainide) under monitoring
    In specialized centers, a controlled infusion can unmask a type-1 pattern if not visible at baseline. Only done with resuscitation backup. PMC

19. Holter monitor / event recorder
    24-hour or longer ECG recording can catch transient type-1 patterns or arrhythmias, often at night. PMC

20. Electrophysiology study (EPS) with programmed ventricular stimulation
    Invasive test that tries to provoke ventricular arrhythmias. Its role in risk stratification is individualized; used more often in symptomatic patients. PMC

E) Imaging tests (to exclude other problems and understand structure)

21. Transthoracic echocardiography (heart ultrasound)
    Most people with Brugada syndrome have normal structure. Echo helps rule out other diseases that can mimic symptoms. PMC

22. Cardiac MRI
    Checks the right ventricle and outflow tract for subtle structural disease or fibrosis that might contribute to arrhythmias; usually normal in pure Brugada. PMC

23. CT coronary angiography / invasive angiography (selected cases)
    Used when symptoms could be from coronary disease; helps exclude ischemia as a cause of arrhythmia. PMC

24. Signal-averaged ECG (SAECG)
    A specialized ECG that looks for late potentials; sometimes abnormal in Brugada syndrome and may add risk information. PMC

25. Right ventricular outflow tract electro-anatomic mapping (specialist centers)
    Research and advanced clinical programs may map abnormal areas that contribute to arrhythmia; mainly in planning ablation in very selected patients. PMC

Non-pharmacological treatments (therapies & others)

1) Fever control with acetaminophen/ibuprofen and hydration (core strategy).
Why: Fever unmasks/augments the Brugada ECG and raises arrhythmia risk. What: At first sign of fever, use standard antipyretics and fluids; seek care if fever persists or you feel faint/palpitations. How it works: Cooling lowers heart-cell temperature-dependent channel dysfunction, stabilizing electrical currents. Keep a home thermometer and antipyretics ready. NCBI+1

2) Strict avoidance of Brugada-risk drugs.
Why: Certain agents (esp. sodium-channel blockers, some antidepressants/antipsychotics, anesthetics) can trigger arrhythmias. What: Cross-check all prescriptions/OTC/herbals on BrugadaDrugs.org and carry a wallet card. How: Avoid or use under specialist supervision, in hospital if necessary. brugadadrugs.org+1

3) Prompt correction of electrolytes (potassium, magnesium, calcium).
Why: Low K⁺/Mg²⁺/Ca²⁺ increases ventricular irritability. What: Treat vomiting/diarrhea early; avoid crash diets/diuretics without monitoring. How: Primary care or ED testing and correction reduce triggers. European Society of Cardiology

4) Avoid heavy alcohol binges and recreational drugs (e.g., cocaine).
Why: Both can precipitate arrhythmias and fevers. What: If you drink, keep to low/moderate amounts; avoid stimulants. How: Lifestyle limits reduce adrenergic/electrical instability. European Society of Cardiology

5) Temperature hygiene during infections.
Why: Viral illnesses commonly raise temperature and risk. What: Keep antipyretics on schedule, rest, hydrate, and seek early medical review. How: Prevents fever-mediated ionic shifts. NCBI

6) Peri-anesthesia planning.
Why: Some anesthetic/analgesic agents appear on avoid lists. What: Provide anesthesia teams with diagnosis in advance; use safer protocols. How: Team consults BrugadaDrugs.org and monitors closely. brugadadrugs.org

7) ECG and clinical follow-up with an electrophysiologist.
Why: Risk can change with age, events, or new meds. What: Periodic ECGs, review of symptoms, and plan updates. How: Early action prevents crises. European Society of Cardiology

8) Home and travel action plan.
Why: Sudden fever, fainting, or palpitations need fast steps. What: Written plan: antipyretics, when to call EMS, which hospital. How: Cuts time to treatment for electrical storms. European Society of Cardiology

9) Family screening and genetic counseling.
Why: First-degree relatives may carry the variant/phenotype. What: Family ECG ± genetics, counseling on triggers. How: Reduces undetected risk. NCBI

10) Consider ICD (implantable cardioverter-defibrillator) in selected patients.
Why: Prevents sudden cardiac death in high-risk (arrest/syncope with documented VT/VF, spontaneous type 1 ECG with arrhythmic events). What/How: Multidisciplinary decision per guidelines. European Society of Cardiology

11) Catheter ablation of arrhythmogenic substrate for recurrent events.
Why: Targeting epicardial RVOT substrate can reduce VF/ICD shocks. What/How: Experienced centers perform substrate ablation guided by mapping. European Society of Cardiology

12) Illness-preparedness kit.
Why: Rapid fever control saves risk. What: Thermometer, antipyretics, oral rehydration salts, written drug-avoid list. How: Practical readiness. brugadadrugs.org

13) Avoid extreme dehydration/sauna/heat exposure.
Why: Dehydration and hyperthermia worsen electrical instability. What: Hydrate; limit sauna time; skip during illness. How: Keeps electrolytes and temperature stable. European Society of Cardiology

14) Avoid large, very late meals if they routinely trigger palpitations.
Why: Vagal swings and reflux can provoke symptoms in some people. What: Small evening meals; observe personal triggers. How: Reduces nocturnal events. NCBI

15) Sleep hygiene and stress management.
Why: Poor sleep and stress increase sympathetic surges. What: Regular sleep, relaxation techniques. How: Smooths autonomic tone. NCBI

16) Patient/partner CPR training and AED awareness.
Why: Early defibrillation saves lives. What: Learn CPR; know AED locations at home/work/gym. How: Improves survival if arrest occurs. European Society of Cardiology

17) Wearable medical ID.
Why: Guides emergency clinicians about drug avoidance and fever protocol. What: Bracelet/card listing “Brugada syndrome—avoid sodium-channel blockers; treat fever.” How: Safer acute care. brugadadrugs.org

18) Careful exercise return after syncope/arrhythmia.
Why: Some episodes cluster after illness/exertion. What: Graduated return with medical guidance. How: Monitored progression reduces risk. European Society of Cardiology

19) Vaccination and infection prevention.
Why: Fewer febrile illnesses mean fewer triggers. What: Keep routine vaccines up to date. How: Prevents fever-related risk. NCBI

20) Shared care plan with primary care, ED, and dentist.
Why: Many settings prescribe meds. What: Put Brugada warnings in the chart everywhere. How: Prevents inadvertent exposure. brugadadrugs.org

---

Drug treatments

Important: In Brugada—including CACNA1C forms—drugs are mainly used for fever control, acute electrical storms, and arrhythmia suppression in selected cases. ICD and ablation remain the definitive options for high-risk patients. Always cross-check each medicine on BrugadaDrugs.org and follow specialist advice. European Society of Cardiology+1

1) Isoproterenol (IV) for electrical storm — drug class: nonselective β-agonist. Typical hospital dosing: titrated IV infusion to raise heart rate and suppress VF; dosing is individualized (per label, IV route; clinical use in Brugada is guideline-endorsed for storms). When/why: First-line emergency therapy to stop recurrent VF during fever/electrical storm. Mechanism: Increases L-type Ca²⁺ current and heart rate, countering phase-2 reentry that drives VF. Side effects: Tachycardia, hypotension, arrhythmias, ischemia; careful monitoring required. Evidence: Guidelines and clinical series support it for Brugada storms; label describes pharmacology/IV administration. FDA Access Data+3European Society of Cardiology+3FDA Access Data+3

2) Quinidine (oral) for arrhythmia suppression — class: class Ia antiarrhythmic. Dose: Patient-specific (e.g., quinidine gluconate/sulfate in divided doses; careful QT and level monitoring). When/why: For recurrent arrhythmias or frequent ICD therapies when ablation isn’t suitable/available; sometimes for high-risk patients not receiving ICD. Mechanism: Blocks Ito and IKr, reducing the epicardial-endocardial voltage gradient and suppressing phase-2 reentry. Side effects: Diarrhea, cinchonism, cytopenias, QT prolongation and torsades; drug–drug interactions (CYP2D6). Evidence/label: ESC guidelines; FDA labels warn torsades risk. European Society of Cardiology+2FDA Access Data+2

3) Acetaminophen (paracetamol) for fever — class: antipyretic/analgesic. Dose/time: Standard OTC adult dosing per label; start at first sign of fever. Purpose: Lower temperature to reduce arrhythmic risk. Mechanism: Central COX inhibition lowers hypothalamic set point. Side effects: Hepatotoxicity with overdose/alcohol. Note: Not specific to Brugada, but fever control is central. (Use national label/OTC monographs.) European Society of Cardiology

4) Ibuprofen for fever/inflammation — class: NSAID. Dose/time: Standard OTC adult dosing with food; alternate with acetaminophen if needed (per clinician advice). Purpose: Additional antipyresis/comfort. Mechanism: Peripheral COX inhibition; lowers prostaglandins/fever. Side effects: GI upset/bleeding, renal effects. (Use national label.) European Society of Cardiology

5) Terbutaline (SC/IV) as alternative β-agonist — class: β2-agonist. Dose: Individualized in hospital (off-label for Brugada storm). Purpose: If isoproterenol unavailable/contraindicated, some centers use terbutaline to raise HR and Ca²⁺ current. Mechanism: β-stimulation increases ICaL and suppresses VF triggers. Side effects: Tremor, tachycardia, hypokalemia. Label evidence: FDA/DailyMed describe dosing and β-agonist effects (Brugada use is off-label). DailyMed+1

6) Cilostazol (oral) as adjunct in selected cases — class: PDE-3 inhibitor, antiplatelet/vasodilator. Dose: 100 mg twice daily is label dose for claudication; Brugada use is off-label and specialist-guided. Purpose: Raise heart rate and ICaL to blunt Brugada phenotype in some reports when quinidine not tolerated. Mechanism: Increases cAMP → β-like effects → more Ca²⁺ current. Side effects/contra: Headache, palpitations; contraindicated in heart failure. Label evidence: FDA labeling. FDA Access Data+2FDA Access Data+2

7) Antiemetics/electrolyte solutions during gastroenteritis — class: supportive meds/ORS. Dose: Per label/clinician advice. Purpose: Prevents hypokalemia/hypomagnesemia and dehydration that trigger arrhythmias. Mechanism: Restores fluid/ion balance. Side effects: Vary by product; avoid QT-prolonging antiemetics if possible (check BrugadaDrugs.org). brugadadrugs.org

8) Magnesium replacement when low — class: electrolyte. Dose: Oral or IV per labs. Purpose: Correct hypomagnesemia that increases ventricular irritability. Mechanism: Stabilizes myocardial electrophysiology. Side effects: GI upset (oral), hypotension (IV if rapid). (General electrolyte guidance within arrhythmia care frameworks.) European Society of Cardiology

9) Potassium replacement when low — class: electrolyte. Dose: Tailored to serum K⁺ with ECG monitoring for IV. Purpose: Avoids hypokalemia-triggered events. Mechanism: Restores repolarization stability. Side effects: GI irritation (oral), arrhythmias if mis-dosed (IV). European Society of Cardiology

10) Antipyretic plan during vaccinations/infections — class: supportive OTCs. Dose/time: Start promptly if fever occurs after vaccination/infections. Purpose: Prevent fever-driven phenotype expression. Mechanism/notes: As above; discuss with clinician to avoid unnecessary dose stacking. NCBI

11) Hospital antipyretic protocol with IV fluids — class: supportive care. Purpose: In the ED, standardized fever/fluids/electrolytes reduce storm risk. Mechanism: Reverses triggers. European Society of Cardiology

12) Short-acting anxiolytics only if needed and vetted — class: anxiolytics (case-by-case). Purpose: Reduce catecholamine surges with panic that might precipitate symptoms; only choices cleared on BrugadaDrugs.org. Mechanism: CNS calming; must avoid unsafe agents. brugadadrugs.org

13) Avoidance of sodium-channel blockers used diagnostically — class: flecainide/ajmaline/procainamide are for diagnosis, not chronic therapy in Brugada; they can unmask patterns and provoke arrhythmias. Purpose: Do not self-expose; diagnostic use only under EP supervision. European Society of Cardiology

14) Careful antibiotic selection during infections — class: antimicrobials. Purpose: Treat infections to control fever while avoiding red/orange list agents. Mechanism: Remove febrile trigger. Note: Clinician should cross-check safety lists. brugadadrugs.org

15) Carefully chosen analgesia/sedation in the ED/OR — class: procedural meds. Purpose: Pain and procedures happen; choose safer agents. Mechanism/notes: Use institutional protocols referencing Brugada lists. brugadadrugs.org

16) Proton-pump inhibitor if NSAIDs required — class: gastroprotection. Purpose: Enables safe antipyretic rotation if GI risk is high. Note: Check each PPI on safety lists. brugadadrugs.org

17) Oral rehydration salts (ORS) — class: electrolyte solution. Purpose: Prevent dehydration-triggered events during febrile gastroenteritis. Mechanism: Balanced glucose-electrolyte absorption. European Society of Cardiology

18) Topical cooling methods with antipyretics — class: supportive. Purpose: Assist temperature reduction when fever is stubborn. Mechanism: Conduction/evaporation cooling. NCBI

19) Hospital telemetry during febrile illness in high-risk patients — class: monitoring. Purpose: Early detection/treatment of arrhythmias. Mechanism: Continuous ECG surveillance. European Society of Cardiology

20) Post-discharge medication reconciliation — class: safety process. Purpose: Prevents inadvertent prescriptions that are unsafe for Brugada. Mechanism: Structured checklist referencing BrugadaDrugs.org. brugadadrugs.org

---

Dietary molecular supplements

There are no supplements proven to treat Brugada syndrome itself. The only evidence-based roles are supporting normal electrolytes and general heart health. Anything that alters cardiac ion channels or QT can be risky. Always clear supplements with your electrophysiologist and cross-check BrugadaDrugs.org.

1. Magnesium (when low or borderline).
   Dose: commonly 200–400 mg elemental/day (check product); adjust to labs. Function: supports membrane stability and reduces ventricular irritability when deficient. Mechanism: cofactor for many ion pumps; stabilizes repolarization. Note: Not a treatment for Brugada; it corrects deficiency only. European Society of Cardiology

2. Potassium (only if low).
   Dose: individualized to serum K⁺; food-first strategy preferred. Function: maintains proper repolarization; low K⁺ increases arrhythmia risk. Mechanism: normalizes transmembrane K⁺ gradients. Caution: Never self-dose high-strength KCl; monitor. European Society of Cardiology

3. Oral rehydration electrolytes.
   Dose: as per packet during illness. Function: prevents dehydration/electrolyte loss. Mechanism: glucose-sodium cotransport aids fluid absorption. European Society of Cardiology

4. Omega-3 (general heart health, not Brugada-specific).
   Dose: commonly ~1 g/day EPA+DHA; discuss bleeding risk. Function: systemic cardiometabolic support. Mechanism: membrane effects; arrhythmia impact in inherited syndromes is uncertain. (Guidelines do not endorse omega-3 for Brugada.) European Society of Cardiology

5. Vitamin D (if deficient).
   Dose: per lab-guided replacement. Function/mechanism: general health; indirect support for muscle function and immunity; no direct Brugada effect. European Society of Cardiology

6. B-complex (if malnourished/deficient).
   Dose: per label if deficiency risk. Function: supports general metabolism; no direct antiarrhythmic effect. European Society of Cardiology

7. CoQ10 (optional, not Brugada-specific).
   Dose: often 100–200 mg/day; discuss interactions (e.g., anticoagulants). Function/mechanism: mitochondrial support; no Brugada evidence—avoid therapeutic claims. European Society of Cardiology

8. Electrolyte-balanced sports solutions (illness/exertion).
   Dose: per need; avoid high-caffeine/energy drinks. Function: maintain fluids/ions; mechanism as ORS. European Society of Cardiology

9. Calcium (only if low).
   Dose: lab-guided; do not oversupplement. Function: supports excitation–contraction; paradoxically, excess calcium supplements are not helpful for Brugada and can cause other issues. European Society of Cardiology

10. Zinc (short course in viral colds if deficient).
    Dose: per label for limited days. Function: may shorten colds, indirectly reducing fever days; not Brugada-specific. European Society of Cardiology

---

Immunity-booster / regenerative / stem-cell drugs

There are no FDA-approved “immunity boosters,” regenerative medicines, or stem-cell drugs for Brugada syndrome (including CACNA1C forms). Using such products outside trials can be unsafe or illegal. Focus on fever prevention/early treatment, guideline-directed acute care (isoproterenol for storms), quinidine in selected cases, substrate ablation when appropriate, and ICD decisions in high risk. European Society of Cardiology+1

---

Procedures/surgeries

1) Implantable cardioverter-defibrillator (ICD).
What: A small device under the skin with leads to the heart that can detect and shock dangerous arrhythmias. Why: Prevents sudden death in survivors of cardiac arrest or clearly high-risk patients (e.g., syncope with documented VT/VF). Notes: Risks include infection, inappropriate shocks, and lead issues; shared decision-making is essential. European Society of Cardiology

2) Epicardial substrate catheter ablation.
What: Mapping the right ventricular outflow tract (often epicardial) to find and ablate abnormal substrate that triggers VF. Why: Reduces recurrent VF and ICD shocks when arrhythmias persist despite medical therapy. Notes: Done at expert centers; can change ECG pattern and outcomes. European Society of Cardiology

3) Electrophysiology (EP) study.
What: Invasive testing to characterize arrhythmia substrate/inducibility. Why: Helps planning ablation and risk assessment in selected patients. European Society of Cardiology

4) Temporary pacing during storms (rare).
What: Temporary transvenous pacing to increase heart rate. Why: Increases ICaL/HR as an adjunct when β-agonists are insufficient/unavailable. European Society of Cardiology

5) Peri-operative anesthesia protocolization (team procedure).
What: Customized anesthetic plan avoiding red/orange list drugs and ensuring temperature/electrolyte control. Why: Safe surgery/ dental work without provoking arrhythmias. brugadadrugs.org

---

Preventions

1. Treat fever immediately with antipyretic + fluids. NCBI

2. Avoid drugs on the Brugada red/orange lists; check every new prescription/OTC/herbal. brugadadrugs.org

3. Keep electrolytes normal—especially during illness/exercise/heat. European Society of Cardiology

4. Limit alcohol; avoid stimulants/recreational drugs. European Society of Cardiology

5. Carry medical ID and an action plan. brugadadrugs.org

6. Inform anesthesia/dentistry teams before any procedure. brugadadrugs.org

7. Vaccinate and practice infection prevention to reduce febrile illnesses. NCBI

8. Keep a thermometer and antipyretics at home/travel. European Society of Cardiology

9. Arrange family screening and genetic counseling. NCBI

10. Maintain regular EP follow-up and device checks if you have an ICD. European Society of Cardiology

---

When to see a doctor

• Immediately if you faint, feel severe palpitations, have chest pain, or feel dizzy/light-headed during a fever—especially if you have a known Brugada diagnosis. In the ED, tell them you have Brugada and show the avoid-drug card so they can use isoproterenol quickly in storms and avoid unsafe medicines. European Society of Cardiology+1

• Same day if you have persistent fever that doesn’t come down with antipyretics, vomiting/diarrhea with dehydration, or new medications started by any clinician who may not know your Brugada status. brugadadrugs.org

• Routinely for scheduled EP follow-up, ECGs, genetic counseling, and device checks. NCBI

---

What to eat and what to avoid

1. Hydration first: water/electrolyte drinks during illness/heat. Prevents electrolyte loss. European Society of Cardiology

2. Potassium-rich foods (bananas, oranges, tomatoes, legumes) if your potassium runs low; confirm with labs if supplementing. European Society of Cardiology

3. Magnesium-containing foods (nuts, seeds, leafy greens) for baseline support. European Society of Cardiology

4. Balanced meals with lean proteins, whole grains, fruits/vegetables; avoid crash diets/fasting that can upset electrolytes. European Society of Cardiology

5. Limit alcohol, avoid binges (arrhythmia trigger). European Society of Cardiology

6. Avoid energy drinks/high-dose caffeine; they may increase adrenergic stress. European Society of Cardiology

7. During fever: light foods you can tolerate, ORS, broths; keep calories/hydration steady. European Society of Cardiology

8. Monitor GI upsets; replace fluids/electrolytes early to protect K⁺/Mg²⁺. European Society of Cardiology

9. Be cautious with herbal products; some affect QT or interact with drugs—check Brugada lists and ask your EP. brugadadrugs.org

10. No special “Brugada diet” is proven—consistency, hydration, and electrolytes matter most. European Society of Cardiology

---

FAQs

1) What exactly makes CACNA1C Brugada different?
It’s the same Brugada clinical picture, but the variant is in CACNA1C, lowering calcium current (ICaL). This shifts electrical balance in the right ventricle and can enable dangerous rhythms—especially with fever or certain drugs. NCBI+1

2) Can I live a normal life?
Many people do. The key is fever control, drug avoidance, and regular specialist follow-up. Risk varies between individuals. European Society of Cardiology

3) Do I need an ICD?
Only if you meet guideline-based high-risk criteria (e.g., prior cardiac arrest, arrhythmic syncope with documented VT/VF). Your electrophysiologist will assess. European Society of Cardiology

4) Are there medicines that “fix” Brugada?
No medicine cures it. Isoproterenol treats acute storms; quinidine can suppress arrhythmias in selected patients; ablation and ICD address ongoing risk. European Society of Cardiology+2FDA Access Data+2

5) Why is fever so dangerous?
Heat further reduces calcium/sodium currents in affected regions, making re-entrant arrhythmias easier. Treat fever quickly. NCBI

6) Which common drugs are unsafe?
Always check BrugadaDrugs.org; red/orange lists include certain antiarrhythmics, antidepressants, antipsychotics, anesthetics, and others. Never start/stop meds without checking. brugadadrugs.org

7) Can exercise trigger events?
Moderate exercise is usually fine once your EP approves. Avoid dehydration/overheating and stop if you feel unwell. European Society of Cardiology

8) Should my family be tested?
Yes—first-degree relatives should have at least an ECG and consider genetic counseling/testing. NCBI

9) Are beta-blockers helpful?
Routine β-blockers are not a standard Brugada therapy and may be neutral or unwanted in some contexts; decisions are individualized. European Society of Cardiology

10) Can I drink coffee?
Small amounts may be fine, but avoid energy drinks/high doses and any personal triggers. Hydrate well. European Society of Cardiology

11) What happens during an electrical storm treatment?
You’ll receive isoproterenol IV (or alternatives) to raise heart rate and stabilize currents, plus antipyretics/fluids and close monitoring. FDA Access Data+1

12) Is ablation a cure?
It can greatly reduce arrhythmias and ICD shocks, but follow-up and trigger control remain important. European Society of Cardiology

13) Do supplements help?
Only to correct deficiencies (e.g., K⁺, Mg²⁺). No supplement cures Brugada. Discuss every product with your EP. European Society of Cardiology

14) Are “stem-cell” or “immunity” drugs available?
No—there are no approved regenerative or immunity-boosting drugs for Brugada. Be cautious about unsupported claims. European Society of Cardiology

15) What should my emergency card say?
“Brugada syndrome (CACNA1C). Avoid Brugada red/orange list drugs; treat fever immediately. If recurrent VF/VT: isoproterenol infusion per protocol. Contact my electrophysiologist.” Include contacts and allergies. brugadadrugs.org+1

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: November 04, 2025.